CO-CRYSTAL OF THE PAR-1 RECEPTOR ANTAGONIST VORAPAXAR AND ASPIRIN
摘要
This invention relates to a co-crystal of vorapaxar and aspirin. The inventive co-crystal antagonizes the PAR-1 receptor. This invention also provides for pharmaceutical compositions comprising the inventive co-crystal as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by antagonizing the PAR-1 receptor.
申请公布号
WO2015013083(A1)
申请公布日期
2015.01.29
申请号
WO2014US46929
申请日期
2014.07.17
申请人
MERCK SHARP & DOHME CORP.;TRZASKA, SCOTT;DURAN-CAPECE, ALICIA, V.;LAMM, MATTHEW
发明人
TRZASKA, SCOTT;DURAN-CAPECE, ALICIA, V.;LAMM, MATTHEW